BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02606305-completion@plaintrial.com
DTSTAMP:20261028T011811Z
DTSTART;VALUE=DATE:20210312
SUMMARY:Study of Mirvetuximab Soravtansine in Combination With Bevacizumab\
 , Carboplatin\, Pegylated Liposomal Doxorubicin\, Pembrolizumab\, or Bevac
 izumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Pos
 itive Advanced Epithelial Ovarian Cancer\, Primary Peritoneal\, or Fallopi
 an Tube Cancer — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT02606305
URL:https://plaintrial.com/trial/NCT02606305
END:VEVENT
END:VCALENDAR